U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06874062) titled 'Evaluation of Primary Tooth Pulpotomy With Resin Modified Calcium Silicate' on March 03.
Brief Summary: The goal of this clinical trial is to evaluate whether Theracal PT, a resin-modified calcium silicate-based material, can be successfully used in pulpotomy treatment for primary molar teeth. The efficacy of this material will be compared with MTA in its putty form (Neoputty) and powder-liquid form (ProRoot). The main questions this study aims to answer are: Is Theracal PT as effective as MTA, the gold standard for pulpotomy treatment? Is Neoputty MTA, which is easier to handle, more effective than ProRoot MTA? The study will incl...